Breast cancer is one of the most common diseases of women, which can increase the survival of patients with its early diagnosis. Despite the existence of relatively sensitive methods of early detection of breast cancer, such as mammography, statistics show that a small number of women perform mammography according to the recommended clinical guidelines. Using the health belief model, this study aims to determine the factors affecting mammography among women teachers in Hamedan. Methods: This study was conducted on 458 female teachers aged 40 years and older of Hamadan city, in western part of Iran, during October to December of 2019. The participants were asked about the factors affecting mammography based on the health belief model. Questionnaires were completed by selfreported method and analyzed by SPSS software at 95% confidence interval. Results: The average age of the study participants was 46±4.1 years. Among the participants, about 41.5% had performed mammography at least once. In univariate analysis, the constructs of the health belief model generally predicts performing mammography between 35 and 49 percent. In multivariate analysis, age 46 to 50 years, having supplementary insurance, history of breast disease, perceived barriers with odds ratio of 3.4, 3.4, 10.6 and .89, respectively, were significantly related to mammography. Conclusions: Female teachers over 45 years of age with a history of breast disease, if they do not have financial or other barriers to do mammography, perform breast cancer screening.
Background: There are a limited number of studies about COVID-19 during delivery and postpartum.Case presentation: A 38-years old G3p2 woman at 35 weeks and 4 days of gestation referred with the chief complaints of dyspnea, cough, headache, and fever. Pharyngeal swab polymerase chain reaction (PCR) was negative for COVID-19; however, in chest computed tomography (CT) angiography, ground glass was observed in the basal lobe of the left lung. The infant was born via cesarean section with gestational age of 36 weeks and an Apgar score of 8/9. No infant document was found about COVID-19 and other infections in several days after delivery. The patient died eight days after the onset of symptoms due to cardiovascular collapse.Conclusions: We reported the first death of postpartum maternal with COVID-19 and a healthy baby with no evidence of COVID-19 and gestational age of 36 weeks.
Pregnant women suffering chronic illness or obstetric complications such as obesity are prone to severe pneumonia and COVID‐19. Obesity in pregnancy is associated with many complications for both mother and fetus. Here, we report the death of an obese mother with COVID‐19.
Introduction::
There are a limited number of studies about COVID-19 during delivery and postpartum.
Case presentation::
A 38 -years- old G3p2 woman at 35 weeks and 4 days of gestation was referred with the chief complaints
of dyspnea, cough, headache, and fever. Pharyngeal swab polymerase chain reaction (PCR) was negative for COVID-19;
however, in chest computed tomography (CT) angiography, ground glass was observed in the basal lobe of the left lung.
The infant was born via cesarean section with a gestational age of 36 weeks and an Apgar score of 8/9. No infant document
was found about COVID-19 and other infections in several days after delivery. The patient died eight days after the onset
of symptoms due to cardiovascular collapse.
Discussion::
we reported the first death of a postpartum maternal with COVID-19 and a healthy baby with no evidence of
COVID-19 and a gestational age of 36 weeks.
Conclusion::
Physicians should be aware that pregnant women with symptoms of respiratory infection and pulse negative
PCR test should be followed for infected with COVID-19. This infection may be led to maternal death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.